Exelixis
EXELExelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Exelixis
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 2/18/2026 | Sell | Hefti, Brenda | SVP and General Counsel | $44.0 | $821,623 |
| 2/18/2026 | Sell | Smith, Julie | Director | $44.4 | $2,849,201 |
| 2/18/2026 | Sell | Wyszomierski, Jack L. | Director | $44.0 | $4,382,252 |
| 2/17/2026 | Sell | Haley, Patrick J. | EVP, Commercial | $43.7 | $2,950,941 |
| 2/17/2026 | Sell | Senner, Christopher J. | EVP and CFO | $43.7 | $1,337,044 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)